Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Axon degeneration in Parkinson's disease
Robert E. Burke, Karen L. O’Malley
Experimental Neurology (2012) Vol. 246, pp. 72-83
Open Access | Times Cited: 442

Showing 1-25 of 442 citing articles:

Selective neuronal vulnerability in Parkinson disease
D. James Surmeier, José Á. Obeso, Glenda M. Halliday
Nature reviews. Neuroscience (2017) Vol. 18, Iss. 2, pp. 101-113
Open Access | Times Cited: 896
Lewy body extracts from Parkinson disease brains trigger α‐synuclein pathology and neurodegeneration in mice and monkeys
Ariadna Recasens, Benjamin Dehay, Jordi Bové, et al.
Annals of Neurology (2013) Vol. 75, Iss. 3, pp. 351-362
Closed Access | Times Cited: 564
Mitophagy of damaged mitochondria occurs locally in distal neuronal axons and requires PINK1 and Parkin
Ghazaleh Ashrafi, Julia S. Schlehe, Matthew J. LaVoie, et al.
The Journal of Cell Biology (2014) Vol. 206, Iss. 5, pp. 655-670
Open Access | Times Cited: 472
Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer’s disease
Annalisa Nobili, Emanuele Claudio Latagliata, Maria Teresa Viscomi, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 410
Living on the edge with too many mouths to feed: Why dopamine neurons die
J. Paul Bolam, Eleftheria K. Pissadaki
Movement Disorders (2012) Vol. 27, Iss. 12, pp. 1478-1483
Open Access | Times Cited: 404
On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease
Nicolas Giguère, Samuel Burke Nanni, Louis‐Éric Trudeau
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 348
Determinants of dopaminergic neuron loss in Parkinson's disease
D. James Surmeier
FEBS Journal (2018) Vol. 285, Iss. 19, pp. 3657-3668
Open Access | Times Cited: 334
Axon Self-Destruction: New Links among SARM1, MAPKs, and NAD+ Metabolism
Josiah Gerdts, Daniel W. Summers, Jeffrey Milbrandt, et al.
Neuron (2016) Vol. 89, Iss. 3, pp. 449-460
Open Access | Times Cited: 310
Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease
Jéssika Cristina Bridi, Frank Hirth
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 300
A LRRK2-Dependent EndophilinA Phosphoswitch Is Critical for Macroautophagy at Presynaptic Terminals
Sandra‐Fausia Soukup, Sabine Kuenen, Roeland Vanhauwaert, et al.
Neuron (2016) Vol. 92, Iss. 4, pp. 829-844
Open Access | Times Cited: 260
Glutamate-induced excitotoxicity in Parkinson's disease: The role of glial cells
Ludovica Iovino, Marie‐Ève Tremblay, Laura Civiero
Journal of Pharmacological Sciences (2020) Vol. 144, Iss. 3, pp. 151-164
Open Access | Times Cited: 260
Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson’s Disease in Rodents
Nicole K. Polinski, Laura A. Volpicelli‐Daley, Caryl E. Sortwell, et al.
Journal of Parkinson s Disease (2018) Vol. 8, Iss. 2, pp. 303-322
Open Access | Times Cited: 221
Functional brain networks and cognitive deficits in Parkinson's disease
Hugo C. Baggio, Roser Sala‐Llonch, Bàrbara Segura, et al.
Human Brain Mapping (2014) Vol. 35, Iss. 9, pp. 4620-4634
Open Access | Times Cited: 213
Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies
Toshiki Uchihara, Benoit I. Giasson
Acta Neuropathologica (2015) Vol. 131, Iss. 1, pp. 49-73
Open Access | Times Cited: 211
The SAC1 domain in synaptojanin is required for autophagosome maturation at presynaptic terminals
Roeland Vanhauwaert, Sabine Kuenen, Roy Masius, et al.
The EMBO Journal (2017) Vol. 36, Iss. 10, pp. 1392-1411
Open Access | Times Cited: 208
New Insights into the Role of Neuron-Specific Enolase in Neuro-Inflammation, Neurodegeneration, and Neuroprotection
Azizul Haque, Rachel Polcyn, Denise Matzelle, et al.
Brain Sciences (2018) Vol. 8, Iss. 2, pp. 33-33
Open Access | Times Cited: 201
Biology of GDNF and its receptors — Relevance for disorders of the central nervous system
Carlos F. Ibáñez, Jaan‐Olle Andressoo
Neurobiology of Disease (2016) Vol. 97, pp. 80-89
Closed Access | Times Cited: 200
Nicotinamide Riboside—The Current State of Research and Therapeutic Uses
Mario Mehmel, Nina Jovanović, Urs Spitz
Nutrients (2020) Vol. 12, Iss. 6, pp. 1616-1616
Open Access | Times Cited: 181
Neuroprotective and Therapeutic Strategies against Parkinson’s Disease: Recent Perspectives
Sumit Sarkar, James Raymick, Syed Imam
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 6, pp. 904-904
Open Access | Times Cited: 177
Increased LRRK2 kinase activity alters neuronal autophagy by disrupting the axonal transport of autophagosomes
C. Alexander Boecker, Juliet Goldsmith, Dan Dou, et al.
Current Biology (2021) Vol. 31, Iss. 10, pp. 2140-2154.e6
Open Access | Times Cited: 135
Impaired dopamine release in Parkinson’s disease
Kaitlyn M. L. Cramb, Dayne Beccano-Kelly, Stephanie J. Cragg, et al.
Brain (2023) Vol. 146, Iss. 8, pp. 3117-3132
Open Access | Times Cited: 88
Neuropathology of incidental Lewy body & prodromal Parkinson’s disease
Thomas Koeglsperger, S Rumpf, Patricia Schließer, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 58
Regulation of Axon Degeneration after Injury and in Development by the Endogenous Calpain Inhibitor Calpastatin
Jing Yang, Robby M. Weimer, Dara Kallop, et al.
Neuron (2013) Vol. 80, Iss. 5, pp. 1175-1189
Open Access | Times Cited: 177
Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's disease
Lars Tönges, Tobias Frank, Lars Tatenhorst, et al.
Brain (2012) Vol. 135, Iss. 11, pp. 3355-3370
Open Access | Times Cited: 168
Review: Axon pathology in age‐related neurodegenerative disorders
Róbert Adalbert, Michael P. Coleman
Neuropathology and Applied Neurobiology (2012) Vol. 39, Iss. 2, pp. 90-108
Closed Access | Times Cited: 164
Page 1 - Next Page

Scroll to top